Kim, C., Spencer, B., Rockenstein, E., Yamakado, H., Mante, M., Adame, A., . . . Masliah, E. (2018). Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Mol Neurodegener.
Chicago Style CitationKim, Changyoun, et al. "Immunotherapy Targeting Toll-like Receptor 2 Alleviates Neurodegeneration in Models of Synucleinopathy By Modulating α-synuclein Transmission and Neuroinflammation." Mol Neurodegener 2018.
Cita MLAKim, Changyoun, et al. "Immunotherapy Targeting Toll-like Receptor 2 Alleviates Neurodegeneration in Models of Synucleinopathy By Modulating α-synuclein Transmission and Neuroinflammation." Mol Neurodegener 2018.
Atenció: Aquestes cites poden no estar 100% correctes.